ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	29 July 2022
Main ID:	NCT00464269
Date of registration:	19/04/2007
Prospective Registration:	Yes
Primary sponsor:	UCB Pharma
Public title:	Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Scientific title:	An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures
Date of first enrolment:	September 2007
Target sample size:	400
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT00464269
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Phase:	Phase 3

Countries of recruitment
Australia	Brazil	Canada	Mexico	United States

Contacts

Name:	UCB Clinical Trial Call Center
Address:
Telephone:
Email:
Affiliation:	+1 877 822 9493 (UCB)

Key inclusion & exclusion criteria

Health Condition(s) or Problem(s) studied

Intervention(s)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Secondary Sponsor(s)

Ethics review

Results

Results available:	Yes
Date Posted:	13/04/2016
Date Completed:
URL:	https://clinicaltrials.gov/ct2/show/results/NCT00464269

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.